Pfizer’s COVID-19 vaccine was granted an emergency use authorization for 12- to 15-year-olds by the U.S. Food & Drug Administration on Monday.

Dr. Michael Smith, a Duke University pediatrician and infectious disease specialist involved in the pediatric trials of the Pfizer COVID-19 vaccine, discussed vaccination of adolescents during a video conference call for the media on Tuesday.

𝐓𝐡𝐞 𝐏𝐚𝐧𝐞𝐥𝐢𝐬𝐭

Dr. Michael Smith is a pediatrician and medical director of the Duke Children's Health Center Infectious Diseases Clinic. He studies antibiotic and vaccine use in children and is a study investigator involved in the pediatric trials of the Pfizer COVID-19 vaccine.

𝐌𝐞𝐝𝐢𝐚 𝐁𝐫𝐢𝐞𝐟𝐢𝐧𝐠𝐬
This video is part of a series of media briefings where Duke experts speak on current issues.

Media Briefings Playlist ➡ [ Ссылка ]

𝐀𝐛𝐨𝐮𝐭 𝐃𝐮𝐤𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
A private research university located in Durham, North Carolina, Duke University is known as one of the world’s leading institutions for education, research, and patient care.

Subscribe ➡ [ Ссылка ]

𝐅𝐨𝐥𝐥𝐨𝐰 #𝐃𝐮𝐤𝐞𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
Home: [ Ссылка ]
News: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]

свернуть